| Oct 11 |
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China
|
| Sep 27 |
Burning Rock CFO resigns
|
| Sep 27 |
Burning Rock Announces Changes to Management and Board of Directors
|
| Aug 23 |
Burning Rock Biotech GAAP EPS of -$0.14, revenue of $18.7M
|
| Aug 23 |
Burning Rock Reports Second Quarter 2024 Financial Results
|
| Aug 19 |
Burning Rock Biotech Limited Announces Expected Delisting of American Depositary Shares
|
| Jul 11 |
Companies Like Burning Rock Biotech (NASDAQ:BNR) Are In A Position To Invest In Growth
|
| Jun 3 |
Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
|
| May 30 |
Burning Rock Biotech joins hands with Bayer to expand precision cancer therapies portfolio
|
| May 30 |
Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
|
